BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15020235)

  • 21. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
    Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells.
    Perks CM; McCaig C; Clarke JB; Clemmons DR; Holly JM
    Biochem Biophys Res Commun; 2002 Jun; 294(5):988-94. PubMed ID: 12074574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
    McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM
    Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
    Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.
    Zi X; Zhang J; Agarwal R; Pollak M
    Cancer Res; 2000 Oct; 60(20):5617-20. PubMed ID: 11059749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
    Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV; Weigel NL
    Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor binding protein-3 mediates IGF-I action in a bovine mammary epithelial cell line independent of an IGF interaction.
    Grill CJ; Cohick WS
    J Cell Physiol; 2000 May; 183(2):273-83. PubMed ID: 10737903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
    Uefuji K; Ichikura T; Shinomiya N; Mochizuki H
    Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L; Fauconnet S; Lamielle F; Adessi GL
    Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of insulin-like growth factors (IGF), FSH, and leptin on IGF-binding-protein mRNA expression in bovine granulosa and theca cells: quantitative detection by real-time PCR.
    Voge JL; Aad PY; Santiago CA; Goad DW; Malayer JR; Allen D; Spicer LJ
    Peptides; 2004 Dec; 25(12):2195-203. PubMed ID: 15572210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S
    Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells.
    Lochrie JD; Phillips K; Tonner E; Flint DJ; Allan GJ; Price NC; Beattie J
    J Cell Physiol; 2006 May; 207(2):471-9. PubMed ID: 16419030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T.
    Frommer KW; Reichenmiller K; Schutt BS; Hoeflich A; Ranke MB; Dodt G; Elmlinger MW
    J Mol Endocrinol; 2006 Aug; 37(1):13-23. PubMed ID: 16901920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor-2 over-rides insulin-like growth factor-I induced proliferation and cell survival in human neuroblastoma cells.
    Russo VC; Andaloro E; Fornaro SA; Najdovska S; Newgreen DF; Bach LA; Werther GA
    J Cell Physiol; 2004 Jun; 199(3):371-80. PubMed ID: 15095284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
    Jendrossek V; Handrick R; Belka C
    FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
    Howe LR; Subbaramaiah K; Patel J; Masferrer JL; Deora A; Hudis C; Thaler HT; Muller WJ; Du B; Brown AM; Dannenberg AJ
    Cancer Res; 2002 Oct; 62(19):5405-7. PubMed ID: 12359744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.